Literature DB >> 21409395

MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

Clemens L Bockmeyer1, Matthias Christgen, Mirco Müller, Sebastian Fischer, Philipp Ahrens, Florian Länger, Hans Kreipe, Ulrich Lehmann.   

Abstract

In order to determine the microRNA expression pattern in normal basal and luminal breast epithelium and to analyze the relationship of this expression pattern to different breast cancer subtypes, laser-microdissected luminal and basal cells isolated from plastic surgery tissue samples were used for comprehensive expression profiling, measuring 664 microRNAs by low-density TaqMan arrays. In a test (n = 5) and validation set (n = 9) 10 differentially expressed microRNAs were identified by TaqMan RT-qPCR. These microRNAs were studied in laser-microdissected cells of luminal A (n = 5), luminal B (n = 5), basal-like subtypes of breast cancer (n = 10), and malignant myoepithelioma of the breast (n = 10). From 116 microRNAs unequivocally expressed in normal breast epithelial cells, we identified 8 basal microRNAs (let7c, miR-125b, miR-126, miR-127-3p, miR-143, miR-145, miR-146b-5p, and miR-199a-3p), preferentially expressed in normal basal cells, exceeding luminal cells by a factor from 4 to 1000. All of these microRNAs were also found to be significantly elevated in malignant myoepithelioma but not in basal-type of breast cancer. Two members of the miR-200 family (miR-200c and miR-429) were predominantly luminal. Both microRNAs were expressed in the luminal and basal type of breast cancer in contrast to malignant myoepithelioma, which revealed significantly lower levels potentially contributing to its mesenchymal phenotype. In conclusion, normal luminal and basal mammary epithelial cells exhibit a different microRNA expression profile. Malignant myoepithelioma seems to exhibit a basal pattern of microRNA expression, whereas the so-called basal-like breast cancer is clearly different and reveals a luminal type pattern.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21409395     DOI: 10.1007/s10549-010-1303-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  66 in total

1.  Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.

Authors:  Thomas J Rogers; Jessica L Christenson; Lisa I Greene; Kathleen I O'Neill; Michelle M Williams; Michael A Gordon; Travis Nemkov; Angelo D'Alessandro; Greg D Degala; Jimin Shin; Aik-Choon Tan; Diana M Cittelly; James R Lambert; Jennifer K Richer
Journal:  Mol Cancer Res       Date:  2018-09-13       Impact factor: 5.852

2.  miR-200a/miR-141 and miR-205 upregulation might be associated with hormone receptor status and prognosis in endometrial carcinomas.

Authors:  Ying Dong; Jing-Wen Si; Wen-Ting Li; Li Liang; Jian Zhao; Mei Zhou; Dong Li; Ting Li
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 3.  MicroRNA expression profiling in archival tissue specimens: methods and data processing.

Authors:  Thomas Streichert; Benjamin Otto; Ulrich Lehmann
Journal:  Mol Biotechnol       Date:  2012-02       Impact factor: 2.695

Review 4.  Role of microRNAs in breast cancer.

Authors:  Ramesh Singh; Yin-Yuan Mo
Journal:  Cancer Biol Ther       Date:  2013-01-04       Impact factor: 4.742

Review 5.  miRNA profiling of cancer.

Authors:  Gianpiero Di Leva; Carlo M Croce
Journal:  Curr Opin Genet Dev       Date:  2013-03-04       Impact factor: 5.578

6.  miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.

Authors:  Zixing Liu; Hao Liu; Shruti Desai; David C Schmitt; Ming Zhou; Hung T Khong; Kristine S Klos; Steven McClellan; Oystein Fodstad; Ming Tan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

7.  A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.

Authors:  Ling Lian; Lujiang Qu; Yanmei Chen; Susan J Lamont; Ning Yang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 8.  [Translational research and diagnostics for breast cancer].

Authors:  H H Kreipe
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

9.  Enrichment for Repopulating Cells and Identification of Differentiation Markers in the Bovine Mammary Gland.

Authors:  Gat Rauner; Itamar Barash
Journal:  J Mammary Gland Biol Neoplasia       Date:  2015-11-28       Impact factor: 2.673

10.  Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis.

Authors:  Jincai Wang; Hong Zhao; Dabei Tang; Jin Wu; Guodong Yao; Qingyuan Zhang
Journal:  Cancer Biother Radiopharm       Date:  2013-04-25       Impact factor: 3.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.